EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Estrogen Receptor Signaling in Breast Cancer

Paulina Miziak iD, Marzena Baran, Ewa Błaszczak iD, Alicja Przybyszewska-Podstawka, Joanna Kałafut iD, Jolanta Smok-Kalwat, Magdalena Dmoszyńska-Graniczka iD, Michał Kiełbus iD, Andrzej Stepulak iD

Cancers · 23.09.2023 · 15 (19) · 4689

DOI: 10.3390/cancers15194689 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 23.09.2023. Verfasst von Paulina Miziak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodzki Street, 20-093 Lublin, Poland. Die Arbeit wurde bisher 218-mal zitiert (Crossref) und nennt 266 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estrogen receptor (ER) signaling is a critical regulator of cell proliferation, differentiation, and survival in breast cancer (BC) and other hormone-sensitive cancers. In this review, we explore the mechanism of ER-dependent downstream signaling in BC and the role of estrogens as growth factors necessary for cancer invasion and dissemination. The significance of the clinical implications of ER signaling in BC, including the potential of endocrine therapies that target estrogens’ synthesis and ER-dependent signal transmission, such as aromatase inhibitors or selective estrogen receptor modulators, is discussed. As a consequence, the challenges associated with the resistance to these therapies resulting from acquired ER mutations and potential strategies to overcome them are the critical point for the new treatment strategies’ development.

Schlagwörter

Stichwörter der Autor:innen

ERER coregulatorsER signalingbreast cancerestrogen receptorpost-translational modificationstherapeutic targeting

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Medical University of Lublin, 1 Chodzki Street, 20-093 Lublin, Poland.
  • Department of Clinical Oncology, Holy Cross Cancer Centre, 3 Artwinskiego Street, 25-734 Kielce, Poland.

ORCID-Profile: Paulina Miziak, Ewa Błaszczak, Joanna Kałafut, Magdalena Dmoszyńska-Graniczka, Michał Kiełbus, Andrzej Stepulak

Förderung

  • Medical University of Lublin

Zitieren

APA

Miziak, P., Baran, M., Błaszczak, E., Przybyszewska-Podstawka, A., Kałafut, J., Smok-Kalwat, J., Dmoszyńska-Graniczka, M., Kiełbus, M., & Stepulak, A. (2023). Estrogen Receptor Signaling in Breast Cancer. Cancers, 15(19), 4689. https://doi.org/10.3390/cancers15194689

Vancouver

Miziak P, Baran M, Błaszczak E, Przybyszewska-Podstawka A, Kałafut J, Smok-Kalwat J, et al. Estrogen Receptor Signaling in Breast Cancer. Cancers. 2023;15(19):4689. doi:10.3390/cancers15194689

BibTeX
@article{Miziak2023,
  author = {Miziak, Paulina and Baran, Marzena and Błaszczak, Ewa and Przybyszewska-Podstawka, Alicja and Kałafut, Joanna and Smok-Kalwat, Jolanta and Dmoszyńska-Graniczka, Magdalena and Kiełbus, Michał and Stepulak, Andrzej},
  title = {Estrogen Receptor Signaling in Breast Cancer},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {19},
  pages = {4689},
  doi = {10.3390/cancers15194689}
}
Kostenlos starten →